Reports
Sale
Global Recombinant Protein Market Size, Growth, Analysis: By Product Type: Growth Factor and Cytokines, Hormone, Enzyme, Antibody, Immune Checkpoint Proteins, Recombinant Regulatory Proteins; By Application: Therapeutic Use, Others; Regional Analysis; Competitive Landscape; Key Trends and Developments in the Market; 2024-2032
Global Recombinant Protein Market Outlook
The global recombinant protein market size reached an estimated value of USD 1.53 billion in 2023. The global market is expected to grow at a CAGR of 12.10% between 2024 and 2032, driven by the increasing demand for effective drugs for chronic diseases.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Recombinant Protein Market Trends
Recombinant proteins are manipulated forms of proteins that are encoded by recombinant DNA. These proteins are commonly used in the production of pharmaceutical products, enzymes, and antibodies for the development of disease treatments.
Producing protein through recombinant DNA technology provides some significant advantages, including the minimized risk of immune reaction and high activity of the protein.
- The market growth is expected to grow in value due to the increasing demand for effective and efficient drugs for improved treatment of patients. The development of such drugs has been sped up due to the creation of various effective recombinant protein-based vaccines created for COVID-19.
-
With the rising demand for effective drugs for specific diseases, key players and government agencies are increasingly investing in the development of novel drugs, which is expected to propel the market development further.
- The rising prevalence of chronic illness is likely to enhance the demand for recombinant protein therapies due to their effectiveness in treating such diseases. The market is expected to expand further with the growing number of cancer cases.
Global Recombinant Protein Market Analysis
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on product type, the market can be segmented into growth factor and cytokines, hormone, enzyme, antibody, immune checkpoint proteins, and recombinant regulatory proteins, among others. Based on application, it can be bifurcated into therapeutic use, research application, and the biotechnology industry. The regional markets for the recombinant protein market can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global recombinant protein market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.
- Abcam PLC
- Thermo Fisher Scientific, Inc.
- Bio-Techne.
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- GeneTex, Inc
- Others
Product Types for Recombinant Proteins in the Market
Based on product type, the market can be divided into growth factor and cytokines, hormone, enzyme, antibody, immune checkpoint proteins, and recombinant regulatory proteins, among others.
The hormone segment is expected to hold a significant share of the market owing to its extensive application in research and development for the creation of treatment options for various diseases, such as diabetes.
The antibody segment is expected to register a high growth rate due to the increasing focus from key players and healthcare institutes in the development of recombinant antibody products. This procedure allows the antibodies to be produced in large quantities after the selection of antibodies with favourable characteristics.
Regional Markets for the Global Recombinant Protein Market
The various regions in the global market include North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. The North American region is expected to hold the largest market share owing to the rising number of patients with diseases such as cancer, diabetes, cardiovascular diseases, and chronic respiratory diseases, among many other diseases.
The market value in the region is likely to develop further with the increasing investment in research and development by major market players and government agencies, owing to the rising demand for effective medicines and treatment options.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
Abcam PLC is one of the leaders in the market, engaged in supplying protein research tools to life scientists. The company specializes in identifying, developing, and distributing high-quality biological reagents and tools that are utilized in the healthcare sector for various purposes including research, drug discovery, and diagnostics.
The company is headquartered in Cambridge, United Kingdom, with a focus on developing products such as primary antibodies, secondary antibodies, proteins and peptides, knockout cell lines and lysates, and cell and tissue imaging tools, among others.
Thermo Fisher Scientific, Inc., based in Massachusetts, United States, is one of the world’s largest biotechnology research companies. The company was formed with the merger of Thermo Electron and Fisher Scientific in 2006. The company specialises in various fields including analytical instruments, laboratory supply chain programs and eCommerce, laboratory equipment, lab services, speciality diagnostics, life sciences, pharma services, and CDMO.
Bio-Techne. is a biotechnology research company based in Minnesota, United States. The company is a leading developer and manufacturer of purified proteins and reagent solutions. In addition, they are also engaged in providing protein analysis solutions. The company was founded in 1981 and has been operating to develop various products including antibodies, enzymes, proteins, and cell culture reagents, among others. Their focus lies in research fields including cancer, cardiovascular biology, cell and gene therapy, and immunology, among others.
Other market players include Merck KGaA, Bio-Rad Laboratories, Inc., and GeneTex, Inc, among others.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Recombinant Protein Market Analysis
8.1 Key Industry Highlights
8.2 Global Recombinant Protein Historical Market (2018-2023)
8.3 Global Recombinant Protein Market Forecast (2024-2032)
8.4 Global Recombinant Protein Market by Product Type
8.4.1 Growth Factor and Cytokines
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2023)
8.4.1.3 Forecast Trend (2024-2032)
8.4.2 Hormone
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2023)
8.4.2.3 Forecast Trend (2024-2032)
8.4.3 Enzyme
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2023)
8.4.3.3 Forecast Trend (2024-2032)
8.4.4 Antibody
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2018-2023)
8.4.4.3 Forecast Trend (2024-2032)
8.4.5 Immune Checkpoint Proteins
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2018-2023)
8.4.5.3 Forecast Trend (2024-2032)
8.4.6 Recombinant Regulatory Proteins
8.4.6.1 Market Share
8.4.6.2 Historical Trend (2018-2023)
8.4.6.3 Forecast Trend (2024-2032)
8.4.7 Others
8.5 Global Recombinant Protein Market by Application
8.5.1 Therapeutic Use
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2023)
8.5.1.3 Forecast Trend (2024-2032)
8.5.2 Research Application
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2023)
8.5.2.3 Forecast Trend (2024-2032)
8.5.3 Biotechnology Industry
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2023)
8.5.3.3 Forecast Trend (2024-2032)
8.6 Global Recombinant Protein Market by Region
8.6.1 North America
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2023)
8.6.1.3 Forecast Trend (2024-2032)
8.6.2 Europe
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2023)
8.6.2.3 Forecast Trend (2024-2032)
8.6.3 Asia Pacific
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2023)
8.6.3.3 Forecast Trend (2024-2032)
8.6.4 Latin America
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2018-2023)
8.6.4.3 Forecast Trend (2024-2032)
8.6.5 Middle East and Africa
8.6.5.1 Market Share
8.6.5.2 Historical Trend (2018-2023)
8.6.5.3 Forecast Trend (2024-2032)
9 North America Recombinant Protein Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2023)
9.1.3 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2023)
9.2.3 Forecast Trend (2024-2032)
10 Europe Recombinant Protein Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2023)
10.1.3 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2023)
10.2.3 Forecast Trend (2024-2032)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2023)
10.3.3 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2023)
10.4.3 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Recombinant Protein Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2023)
11.1.3 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2023)
11.2.3 Forecast Trend (2024-2032)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2023)
11.3.3 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2023)
11.4.3 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2023)
11.5.3 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Recombinant Protein Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2023)
12.1.3 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2023)
12.2.3 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2023)
12.3.3 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Recombinant Protein Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2023)
13.1.3 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2023)
13.2.3 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2023)
13.3.3 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2023)
13.4.3 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Abcam PLC
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Thermo Fisher Scientific, Inc.
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Bio-Techne.
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Merck KGaA
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Bio-Rad Laboratories, Inc.
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 GeneTex, Inc
16.2.6.1 Company Overview
16.2.6.2 Product Portfolio
16.2.6.3 Demographic Reach and Achievements
16.2.6.4 Certifications
16.2.7 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Recombinant Protein Market: Key Industry Highlights, 2018 and 2032
2. Global Recombinant Protein Historical Market: Breakup by Product Type (USD Billion), 2018-2023
3. Global Recombinant Protein Market Forecast: Breakup by Product Type (USD Billion), 2024-2032
4. Global Recombinant Protein Historical Market: Breakup by Application (USD Billion), 2018-2023
5. Global Recombinant Protein Market Forecast: Breakup by Application (USD Billion), 2024-2032
6. Global Recombinant Protein Historical Market: Breakup by Region (USD Billion), 2018-2023
7. Global Recombinant Protein Market Forecast: Breakup by Region (USD Billion), 2024-2032
8. North America Recombinant Protein Historical Market: Breakup by Country (USD Billion), 2018-2023
9. North America Recombinant Protein Market Forecast: Breakup by Country (USD Billion), 2024-2032
10. Europe Recombinant Protein Historical Market: Breakup by Country (USD Billion), 2018-2023
11. Europe Recombinant Protein Market Forecast: Breakup by Country (USD Billion), 2024-2032
12. Asia Pacific Recombinant Protein Historical Market: Breakup by Country (USD Billion), 2018-2023
13. Asia Pacific Recombinant Protein Market Forecast: Breakup by Country (USD Billion), 2024-2032
14. Latin America Recombinant Protein Historical Market: Breakup by Country (USD Billion), 2018-2023
15. Latin America Recombinant Protein Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Middle East and Africa Recombinant Protein Historical Market: Breakup by Country (USD Billion), 2018-2023
17. Middle East and Africa Recombinant Protein Market Forecast: Breakup by Country (USD Billion), 2024-2032
18. Global Recombinant Protein Market Structure
Key Questions Answered in the Report
The global market size for recombinant protein reached an approximate size of USD 1.53 billion in 2023.
The market is expected to grow at a CAGR of around 12.10% during the forecast period of 2024-2032.
The market growth is driven by the growing demand for recombinant protein drugs for the treatment of chronic diseases and the increasing demand for such drugs due to the rising prevalence of diseases such as diabetes and cancer, among others.
The increasing investments by government agencies and key players for the development of new and effective medicine are expected to offer new growth opportunities to the market.
The regional markets for the recombinant protein include North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.
The products available in the market include growth factor and cytokines, hormone, enzyme, antibody, immune checkpoint proteins, and recombinant regulatory proteins, among others.
The recombinant protein technology is applied in therapeutic use, research application, and the biotechnology industry.
The key players in the market include Abcam PLC, Thermo Fisher Scientific, Inc., Bio-Techne., Merck KGaA, Bio-Rad Laboratories, Inc., and GeneTex, Inc, among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 2199
$1799
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 3199
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 4199
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 5199
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER